Progress of Nimotuzumab Application in Nasopharyngeal Carcinoma

Compared with the global average, the incidence rate of nasopharyngeal carcinoma (NPC) in China is higher, particularly in the southern regions where the mortality rate has remained persistently high. Nimotuzumab, a targeted therapy that acts on the epidermal growth factor receptor, has prompted con...

Descripció completa

Dades bibliogràfiques

Autors principals:	Tianci LIANG, Yue ZHAO, Chenchen SONG, Chaoyi ZHANG, Chen CHEN, Qiaoran LI, Biaoxue RONG
Format:	Artigo
Idioma:	Chinês
Publicat:	Magazine House of Cancer Research on Prevention and Treatment 2024-11-01
Col·lecció:	Zhongliu Fangzhi Yanjiu
Matèries:	nasopharyngeal carcinoma nimotuzumab epidermal growth factor receptor targeted therapy antitumor treatment
Accés en línia:	http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2024.24.0362
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!